本文選題：Wilson病 + 凍結(jié)步態(tài)�。� 參考：《安徽中醫(yī)藥大學(xué)》2017年碩士論文

【摘要】：Wilson病(Wilson disease,WD)是一種以銅代謝異常為主的神經(jīng)系統(tǒng)遺傳性疾病,主要由于體內(nèi)銅元素的異常蓄積導(dǎo)致肝臟或/及腦損害,步態(tài)異常亦為WD錐體外系常見表現(xiàn),有不少WD患者可發(fā)生不同程度的凍結(jié)步態(tài),目前對WD患者凍結(jié)步態(tài)的臨床特征及發(fā)生機制研究的文獻較少,WD并發(fā)凍結(jié)步態(tài)的相關(guān)機制有待深入研究。目的:分析WD患者凍結(jié)步態(tài)的臨床特征,探討凍結(jié)步態(tài)與WD患者的臨床分型、發(fā)病年齡、首發(fā)癥狀、病程以及認知、情感的關(guān)系,分析WD患者凍結(jié)步態(tài)可能的發(fā)病機制;探討利用U型電子步道系統(tǒng)評估WD患者凍結(jié)步態(tài)嚴重程度的客觀化指標;對WD患者中西結(jié)合驅(qū)銅治療前后凍結(jié)步態(tài)的改善情況進行研究。方法:1.研究對象選取2016年1月至2016年11月我院住院的WD腦型和或腦內(nèi)臟型患者,實驗組為WD合并凍結(jié)步態(tài)患者20例;對照組為WD未合并凍結(jié)步態(tài)患者20例。2.收集入組的WD患者的一般臨床資料,記錄年齡、性別、病程、分型、分級、多巴胺類等藥物服用情況。3.對入組的WD患者,在治療前進行蒙特利爾認知評估量表(MoCA量表)、HANMILTON焦慮量表、凍結(jié)足問卷(freezing of gait questionnaire FOGQ)量表的問卷調(diào)查。4.應(yīng)用中科院與我院合作研發(fā)的運動障礙疾病數(shù)字化客觀分析系統(tǒng),檢測患者步態(tài)的時空參數(shù)包括步長、步速及雙支撐時間占周期比(DST/GC)。5.驅(qū)銅治療方法為肝豆片口服1.35g/日3次;二巰基丙磺鈉(Sodium Dimercaptopropane Sulfonate,DMPS),靜脈注射,20mg/kg/日。6.對入組的患者(對照組及實驗組)行中西醫(yī)結(jié)合驅(qū)銅綜合治療10療程后,復(fù)行上述數(shù)字化客觀分析系統(tǒng)、多種量表檢查。結(jié)果:1.本研究統(tǒng)計了2016年1月至2016年11月我院住院患者中入組患者含實驗組20例,其中男性12例,女性8例;對照組20例,其中男性9例,女性11例;實驗組年齡為23.5±7歲,病程為6.47±4.32年,分級為3.05±0.605級;對照組年齡24.7±8歲,病程為6.35±5.66年,分級為2.95±0.51級,20例WD合并凍結(jié)患者中18例存在不同程度的肌張力障礙,16例表現(xiàn)有肌僵直,12例表現(xiàn)有不同程度構(gòu)音障礙;20例WD合并凍結(jié)步態(tài)的患者中用改良Goldstein分級時分為Ⅲ、Ⅳ級占85%,有12例(60%)患者病程超過3年。2.實驗組WD患者年齡與療前FOGQ評分相關(guān)性分析得出r=-0.329,p0.05,WD患者年齡與療前FOGQ評分無相關(guān)性;實驗組WD患者病程與療前FOGQ評分相關(guān)性分析得出r=0.070,p0.05,WD患者病程與療前FOGQ評分間無相關(guān)性;凍結(jié)步態(tài)的病程為(3.4±4.5年)與療前FOGQ評分相關(guān)性分析得出,r=-0.034,p=0.8880.05,兩者無相關(guān)性。表明WD患者凍結(jié)步態(tài)的嚴重程度與患者年齡、病程、凍結(jié)步態(tài)的病程無相關(guān)性。3.療前實驗組MoCA總分為27.35±1.23,對照組MoCA總分為28.15±1.27,二者比較,p0.05,兩者MoCA總分之間差異性無統(tǒng)計學(xué)意義;兩組MoCA分項中的視空間與執(zhí)行功能得分比較,實驗組得分為3.85±1.04,對照組得分為4.65±0.67,兩者比較p0.05,實驗組視空間與執(zhí)行功能得分較對照組低,二者差異具有統(tǒng)計學(xué)意義,其余分項(命名、注意、語言、抽象、延遲記憶、定向)評分比較p0.05,無統(tǒng)計學(xué)意義,表明視空間與執(zhí)行功能障礙可能與WD患者發(fā)生凍結(jié)步態(tài)癥狀有關(guān)。4.實驗組患者HANMILTON焦慮量表評分無焦慮(7分)7例占35%,可能焦慮(≥7分)3例占15%,肯定焦慮(≥14分)9例占45%,明顯焦慮(≥21分)1例占5%,嚴重焦慮(≥29分)的0例,肯定焦慮以上患者10例占50%;20例對照組中肯定焦慮以上的患者3例占15%。療前實驗組與對照組患者在HANMILTON焦慮量表評分分值間比較,實驗組評分為11.95±5.54,對照組評分為7.25±5.04,實驗組與對照組患者評分經(jīng)兩獨立樣本均數(shù)t檢驗得出t=2.805,p=0.000.05,WD合并凍結(jié)步態(tài)患者多存在焦慮癥狀,焦慮癥狀可能與WD患者凍結(jié)步態(tài)的發(fā)生存在一定關(guān)系。5.通過對實驗組與對照組步態(tài)參數(shù)比較,兩組步長(m)比較得出,實驗組為0.336±0.097m,對照組0.546±0.029m,實驗組步長低于對照組,兩者存在顯著統(tǒng)計學(xué)意義(p0.05);兩組步速(m/s)比較得出,實驗組為0.517±0.161 m/s,對照組為1.189±0.128 m/s,實驗組較對照組步速減低,其差異性存在統(tǒng)計學(xué)意義(p0.05);DST/GC比較得出,實驗組為0.406±0.083,對照組為0.241±0.042,實驗組較對照組增高,兩者差異存在統(tǒng)計學(xué)意義(p0.05),表明WD合并凍結(jié)步態(tài)患者的步長縮短、步速減慢、DST/GC增高。6.通過對實驗組FOGQ評分與步長、步速以及DST/GC的相關(guān)性分析,得出實驗組步長與FOGQ評分相關(guān)性分析,p0.05,兩者呈線性相關(guān),r=-0.8820,說明兩者呈負相關(guān),FOGQ評分越高,患者步長越短;實驗組步速與FOGQ評分相關(guān)性分析,p0.05,兩者為線性相關(guān),r=-0.6510,兩者呈負相關(guān),FOGQ評分越高,患者步速越慢。實驗組DST/GC值與FOGQ評分相關(guān)性分析,p0.05,r=0.8760,說明兩者呈正相關(guān),FOGQ評分越高DST/GC值也越高,表明基于柔性力敏壓力傳感器搭建的U型步態(tài)通道系統(tǒng)提取的步態(tài)參數(shù)(步長、步速及DST/GC)可反應(yīng)WD患者凍結(jié)步態(tài)的嚴重程度,患者凍結(jié)步態(tài)癥狀越嚴重步長越短,步速越慢,雙支撐時間占周期比值越高。7.實驗組療前步長為0.336±0.097m,經(jīng)10療程中西醫(yī)結(jié)合驅(qū)銅治療后為0.366±0.104m,療后較療前步長增加,兩者比較p0.05,兩者差異具有統(tǒng)計學(xué)意義;實驗組療前步速為0.517±0.161 m/s,療后為0.928±0.138 m/s,療后患者步速較療前增加,兩者比較p0.05,兩者差異具有統(tǒng)計學(xué)意義;治療前后DST/GC比較,治療前DST/GC值為0.406±0.083,治療后為0.361±0.080,較療前DST/GC值減小,兩者比較p0.05,兩者差異具有統(tǒng)計學(xué)意義;治療前后FOGQ評分比較,治療前FOGQ評分為9.30±3.21,治療后FOGQ評分為7.50±2.03,療后較療前FOGQ評分減低,兩者比較p0.05,兩者差異具有統(tǒng)計學(xué)意義。表明經(jīng)中西醫(yī)結(jié)合驅(qū)銅治療可改善WD患者的凍結(jié)步態(tài)癥狀。8.20例實驗組患者療前HANMILTON焦慮量表評分肯定焦慮以上患者10例占50%;經(jīng)中西醫(yī)結(jié)合驅(qū)銅治療療后,肯定焦慮以上患者(≥14分)3例占15%,療前實驗組HANMILTON焦慮量表評分為11.95±5.54,療后為9.45±4.49,經(jīng)配對樣本均數(shù)的t檢驗得出,t=5.008,p0.05,表明WD合并凍結(jié)步態(tài)患者經(jīng)DMPS聯(lián)合肝豆片中西醫(yī)結(jié)合驅(qū)銅治療10個療程后,凍結(jié)步態(tài)改善的同時,焦慮癥狀也有所改善。結(jié)論:1.本組WD患者出現(xiàn)凍結(jié)步態(tài)癥狀多為青年,且病程較長病情較嚴重;往往以腦型癥狀起病,但以凍結(jié)步態(tài)表現(xiàn)為首發(fā)癥狀較少;WD合并凍結(jié)步態(tài)患者病程中較常合并不同程度的肌張力障礙、肌僵直及構(gòu)音障礙。2.WD患者凍結(jié)步態(tài)的發(fā)生與患者焦慮情緒及認知功能中視空間障礙存在一定相關(guān)性。3.基于柔性力敏壓力傳感器搭建的U型步態(tài)通道系統(tǒng)提取WD患者的步長、步速及DST/GC參數(shù)可用于評估WD患者凍結(jié)步態(tài)的嚴重程度,能為WD患者凍結(jié)步態(tài)的評估提供客觀化依據(jù)。4.肝豆片聯(lián)合DMPS中西醫(yī)結(jié)合驅(qū)銅治療可以很好的改善WD患者凍結(jié)步態(tài)癥狀。
[Abstract]:Wilson disease (Wilson disease, WD) is a kind of hereditary disease of nervous system, mainly due to abnormal copper metabolism. It is mainly caused by the abnormal accumulation of copper elements in the body and causes liver or / and brain damage. The abnormal gait is also common in the extrapyramidal system of WD. There are many WD patients with different degrees of freezing gait, and the frozen gait of WD patients is present. There are few literatures on the bed characteristics and mechanism of occurrence. The mechanism of WD concurrent frozen gait needs to be studied. Objective: to analyze the clinical characteristics of frozen gait in WD patients and to explore the clinical classification of frozen gait and WD patients, the age of onset, the first symptoms, the course of disease, the relationship of cognition and emotion, and analyze the possible pathogenesis of the frozen gait of WD patients. The objective index of evaluating the severity of the frozen gait of WD patients was evaluated by U type electronic trail system, and the improvement of the frozen gait in the combination of Chinese and Western copper flooding in WD patients was studied. Methods: 1. the subjects selected the WD brain and or visceral type patients hospitalized in our hospital from January 2016 to November 2016, and the experimental group was combined with WD. 20 cases of frozen gait patients were frozen, and the control group was the general clinical data of the WD patients who were collected in the group of 20 patients with WD without frozen gait. The age, sex, course of disease, classification, classification, dopamine and other drugs were recorded in the group of WD patients with.3., and the Montreal cognitive assessment scale (MoCA scale) and HANMILTON anxiety scale were carried out in the treatment. A questionnaire (freezing of gait questionnaire FOGQ) questionnaire survey.4. application in the digital objective analysis system of dyskinesia developed by the Academy of Sciences and our institute. The space-time parameters of the gait of patients include step length, step speed and double support time ratio (DST/GC).5. flooding method for oral 1.35g/ day of liver bean tablets. 3 times; two Sodium Dimercaptopropane Sulfonate, DMPS), intravenous injection, 20mg/kg/ day.6. to the group of patients (control group and experimental group) with the combination of Western medicine and the 10 course of treatment, the above digital objective analysis system, multiple scale examination. Results: 1. studies statistics from January 2016 to November 2016 our hospital. In the hospitalized patients, 20 cases were included in the experimental group, including 12 males and 8 females, and 20 cases in the control group, including 9 males and 11 females. The age of the experimental group was 23.5 + 7 years, the course of disease was 6.47 + 4.32 years, and the control group was 9 years old. There were different degree of dystonia, 16 cases showed muscle stiffness, 12 cases had different degree of dysarthria, 20 cases of WD combined with frozen gait with modified Goldstein grade III, grade IV, 85%, and 12 (60%) patients for more than 3 years.2. experimental group and FOGQ score of r=-0.329, P0 .05, WD patients were not related to the FOGQ score before treatment, and the correlation analysis between the course of the patients in the experimental group and the pre therapy FOGQ score showed that there was no correlation between the course of r=0.070, P0.05, WD patients and the preoperative FOGQ score; the course of the frozen gait was (3.4 + 4.5 years) and the correlation analysis of the FOGQ score before the treatment, r=-0.034, p=0.8880.05, there was no correlation between them. The severity of frozen gait in the patients with WD was not related to the patient's age, course of disease, and the course of the frozen gait. The total score of MoCA in the experimental group before.3. was 27.35 + 1.23, the total score of MoCA in the control group was 28.15 + 1.27, and the two was compared, P0.05, and the difference of the total MoCA score between the two groups was not statistically significant; the visual space and the executive function scores in the two group MoCA sub items were compared, The score of the experimental group was 3.85 + 1.04, the score of the control group was 4.65 + 0.67. The scores of the two groups were P0.05. The scores of visual space and executive function in the experimental group were lower than those of the control group. The difference between the two groups was statistically significant. The other sub items (naming, attention, language, abstract, delayed memory, orientation) were compared with P0.05, which showed that the visual space and executive dysfunction were not statistically significant. The symptoms of frozen gait in WD patients might be related to the symptoms of HANMILTON anxiety in the.4. experimental group. The anxiety scale of the HANMILTON was 35%, the anxiety (> 7) was 15%, the anxiety (> 14) 9 cases was 45%, the anxiety (> 21) was 1 and the serious anxiety (> 29). 3 patients with positive anxiety were compared with the scores of the HANMILTON anxiety scale in the experimental group before 15%. and the control group. The score of the experimental group was 11.95 + 5.54 and the control group was 7.25 + 5.04. The patients in the experimental group and the control group were evaluated by the two independent samples by T test to obtain t= 2.805, p=0.000.05, WD combined with frozen gait patients. In anxiety symptoms, anxiety symptoms may have a certain relationship with the occurrence of frozen gait in WD patients.5. through the comparison of the gait parameters of the experimental group and the control group, the two groups of step length (m) compared, the experimental group was 0.336 + 0.097m, the control group was 0.546 + 0.029m, the experimental group was lower than the control group, the two groups had significant statistical significance (P0.05); m /s) compared with the experimental group, the experimental group was 0.517 + 0.161 m/s, the control group was 1.189 + 0.128 m/s, the experimental group was lower than the control group, and the difference was statistically significant (P0.05). Compared with DST/GC, the experimental group was 0.406 + 0.083, the control group was 0.241 + 0.042, the experimental group was higher than the control group, and the difference was statistically significant (P0.05), indicating WD combination. And the step length of the frozen gait patient was shortened, the pace slowed, and the DST/GC increased.6. through the correlation analysis of the FOGQ score of the experimental group and the pace, the pace and the DST/GC, and obtained the correlation analysis between the step length and the FOGQ score of the experimental group, and P0.05, the two showed linear correlation, r=-0.8820, the higher the FOGQ score, the shorter the pace of the patients, the shorter the pace of the patients; the experimental group. The correlation analysis between the speed and the FOGQ score, P0.05, the linear correlation between the two, r=-0.6510, the negative correlation between the two, the higher the FOGQ score, the slower the pace of the patients. The DST/GC value of the experimental group is correlated with the FOGQ score, P0.05, r=0.8760, indicating that the higher the FOGQ score is, the higher the DST/ GC is, indicating the U based on the flexible force sensitive pressure sensor. The gait parameters (step length, step speed and DST/GC) extracted from the gait channel system can reflect the severity of the frozen gait of the patients with WD. The more serious the severity of the gait of the patients is, the more serious the step of the gait symptoms of the patients, the slower the pace, the higher the ratio of the double support time to the period of the period of the.7. experimental group, which is 0.336 + 0.097m before the treatment of the 10 course of combination of Chinese and Western medicine and 0.366 + 0 after the treatment. .104m, after treatment, compared with P0.05, compared with the two, the difference has statistical significance; the experimental group was 0.517 + 0.161 m/s before treatment and 0.928 + 0.138 m/s after treatment. After treatment, the pace of the patients was increased compared to that before treatment, and the two were P0.05, the difference was statistically significant. The DST/GC value before and after treatment was 0.406 + 0.083, before and after treatment. After treatment, 0.361 + 0.080, compared with pre treatment DST/GC value decreased, the two were compared P0.05, the difference was statistically significant. Before and after treatment, FOGQ score was compared, before treatment, FOGQ score was 9.30 + 3.21, after treatment, FOGQ score was 7.50 + 2.03, after treatment compared with pre treatment FOGQ score decreased, the two were compared to P0.05, the difference was statistically significant. Indicated through traditional Chinese and Western medicine. The combined treatment of copper flooding can improve the frozen gait symptoms of WD patients in.8.20 experimental group. The HANMILTON anxiety scale of the patients in the experimental group was 50%. After the treatment by the combination of Chinese and Western medicine, 3 cases (14) were 15%, the HANMILTON anxiety scale was 11.95 + 5.54 in the pre treatment group and 9.4 after the treatment. 5 + 4.49, according to the t test of the average number of paired samples, t=5.008, P0.05, indicating that the WD combined with the frozen gait after 10 courses of treatment with DMPS combined with the combination of Western medicine in the liver, the frozen gait improved and the anxiety symptoms improved. Conclusion: 1. groups of WD patients with frozen gait symptoms are mostly young, and the longer course of the disease is stricter. Heavy; often with brain type symptoms, but with frozen gait performance as the first symptom, WD combined with frozen gait in the course of patients with different degrees of dystonia, muscle stiffness and dysarthria.2.WD patients' frozen gait is related to the patient's anxiety and cognitive ability in the visual spatial disorder,.3. based on softness The U gait channel system built by the sex sensitive pressure sensor can extract the step length of the WD patients, the step speed and the DST/GC parameters can be used to evaluate the severity of the frozen gait of the WD patients. It can provide an objective basis for the assessment of the frozen gait of the patients with WD, which can improve the frozen gait of the WD patients with the combination of the combination of the.4. and the combination of Chinese and Western medicine and the combination of Chinese and Western medicine in the treatment of the frozen gait of the patients with WD. Symptom.
【學(xué)位授予單位】：安徽中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R742.4

【相似文獻】

相關(guān)期刊論文 前10條

1 胡雪艷,惲?xí)云?步態(tài)分析在臨床中的應(yīng)用[J];中國康復(fù)理論與實踐;2003年11期

2 門洪學(xué);張國棟;吳其常;卞傳華;李曉光;;靴式步態(tài)系統(tǒng)的研制與206名正常青年人步態(tài)分析[J];小兒麻痹研究;1990年02期

3 ;《臨床實用步態(tài)分析學(xué)》[J];中國康復(fù)醫(yī)學(xué)雜志;1993年06期

4 ;新書介紹——臨床實用步態(tài)分析學(xué)[J];骨與關(guān)節(jié)損傷雜志;1993年04期

5 ;98篇有關(guān)步態(tài)分析的文獻信息(續(xù)前)(英文)[J];國外醫(yī)學(xué)(物理醫(yī)學(xué)與康復(fù)學(xué)分冊);1998年04期

6 張福金;臨床步態(tài)分析[J];國外醫(yī)學(xué)(物理醫(yī)學(xué)與康復(fù)學(xué)分冊);1999年03期

7 張瑞紅,王人成,金德聞,張濟川;不同路況下的人體步態(tài)微機檢測[J];現(xiàn)代康復(fù);2000年05期

8 吳文;異常步態(tài)模仿演示在步態(tài)分析教學(xué)中的價值[J];中國康復(fù);2001年01期

9 宋蘭欣;步態(tài)分析在神經(jīng)系統(tǒng)疾病患者康復(fù)中的應(yīng)用[J];中國臨床康復(fù);2005年29期

10 孫嘉利;唐丹;鐘世鎮(zhèn);;三維步態(tài)分析的研究與應(yīng)用[J];中國組織工程研究與臨床康復(fù);2007年05期

相關(guān)會議論文 前10條

1 張麗艷;高艷鳳;王振玲;;偏癱病人的步態(tài)分析[A];中國康復(fù)醫(yī)學(xué)會第三次康復(fù)治療學(xué)術(shù)大會論文匯編[C];2002年

2 王連成;許世波;;步態(tài)分析測試在老年人跌到風(fēng)險評估中的應(yīng)用[A];中國康復(fù)醫(yī)學(xué)會運動療法分會第十一屆全國康復(fù)學(xué)術(shù)大會學(xué)術(shù)會議論文摘要匯編[C];2011年

3 岳雨珊;俞君;朱毅;;三維步態(tài)分析的研究進展及其局限性[A];首屆全國腦外傷治療與康復(fù)學(xué)術(shù)大會論文匯編（下）[C];2011年

4 朱波;王志彬;;步態(tài)分析方法在臨床治療與康復(fù)中的應(yīng)用[A];第11屆全國中西醫(yī)結(jié)合骨傷科學(xué)術(shù)研討會論文匯編[C];2003年

5 曾仁迪;陳德請;李世文;;紅外光技術(shù)于步態(tài)分析上的應(yīng)用[A];2005年海峽兩岸三地?zé)o線科技學(xué)術(shù)會論文集[C];2005年

6 程梟;;常見中樞性運動控制障礙異常步態(tài)的分析與訓(xùn)練[A];2013浙江省物理醫(yī)學(xué)與康復(fù)學(xué)學(xué)術(shù)年會暨第八屆浙江省康復(fù)醫(yī)學(xué)發(fā)展論壇論文集[C];2013年

7 黃燕平;范昕;;談步態(tài)分析[A];第12屆全國運動生物力學(xué)學(xué)術(shù)交流大會論文匯編[C];2008年

8 侯來永;謝欲曉;孫啟良;;偏癱患者異常步態(tài)的矯正訓(xùn)練[A];第四屆全國康復(fù)治療學(xué)術(shù)大會論文摘要匯編[C];2004年

9 趙國如;任露泉;田麗梅;;人體步態(tài)信息測量方法及其工程應(yīng)用前景探討[A];農(nóng)業(yè)機械化與新農(nóng)村建設(shè)——中國農(nóng)業(yè)機械學(xué)會2006年學(xué)術(shù)年會論文集（上冊）[C];2006年

10 李巖;顧旭東;姚云海;吳華;李輝;王偉;;骨盆強化訓(xùn)練對偏癱患者步態(tài)的影響[A];中國康復(fù)醫(yī)學(xué)會腦血管病專業(yè)委員會換屆暨第十五次全國腦血管病康復(fù)學(xué)術(shù)年會、湖南省康復(fù)醫(yī)學(xué)會神經(jīng)康復(fù)專業(yè)委員會2012學(xué)術(shù)年會論文集[C];2012年

相關(guān)重要報紙文章 前1條

1 楊力勇 吳玉璽;神經(jīng)疾病步態(tài)分析技術(shù)獲突破[N];健康報;2006年

相關(guān)博士學(xué)位論文 前10條

1 朱世兵;基于遷移行為、食性分析的貂熊冬季生境利用和評價[D];東北林業(yè)大學(xué);2015年

2 韓云峰;楔形平面及鞋墊對直立及步態(tài)中下肢生物力學(xué)的影響[D];北京體育大學(xué);2016年

3 蘇海龍;步態(tài)失穩(wěn)行為機理及其綜合評價性態(tài)指標研究[D];天津大學(xué);2013年

4 趙凌燕;人體步態(tài)模型實驗研究[D];哈爾濱工程大學(xué);2008年

5 余聯(lián)慶;仿馬四足機器人機構(gòu)分析與步態(tài)研究[D];華中科技大學(xué);2007年

6 馬勤勇;基于步態(tài)的身份識別研究[D];浙江大學(xué);2008年

7 許勝強;帕金森病患者步態(tài)障礙定量評估及量化分級評估方法研究[D];中國科學(xué)技術(shù)大學(xué);2017年

8 鄒曉峰;士兵在負重行軍時步態(tài)的生物力學(xué)特征[D];北京體育大學(xué);2010年

9 熊然;全膝關(guān)節(jié)置換術(shù)后三維步態(tài)分析與個性化多體動力學(xué)建模初步探索[D];第三軍醫(yī)大學(xué);2017年

10 姚志明;基于步態(tài)觸覺信息的身份識別研究[D];中國科學(xué)技術(shù)大學(xué);2010年

相關(guān)碩士學(xué)位論文 前10條

1 項尚;Wilson病患者凍結(jié)步態(tài)的臨床特征、客觀化評估及中西醫(yī)結(jié)合驅(qū)銅治療療效研究[D];安徽中醫(yī)藥大學(xué);2017年

2 趙爽宇;四足仿生機器人步態(tài)控制與切換策略分析[D];電子科技大學(xué);2014年

3 季冉;基于慣性傳感器的步態(tài)測量方法研究與實現(xiàn)[D];大連理工大學(xué);2015年

4 宋佃成;異構(gòu)雙腿行走機器人步態(tài)對稱性與步態(tài)模式研究[D];東北大學(xué);2013年

5 劉亞平;7～12歲兒童步態(tài)動作發(fā)展特征研究[D];河北師范大學(xué);2016年

6 李慧敏;基于機器視覺的步態(tài)模式識別與步態(tài)對稱性研究[D];東北大學(xué);2014年

7 顧琳燕;基于步態(tài)分析的運動康復(fù)評價方法研究[D];浙江大學(xué);2016年

8 余俊飛;基于人體腳部靜電的膝關(guān)節(jié)受限步態(tài)分析與分類識別[D];北京理工大學(xué);2016年

9 茍歡;下肢外骨骼機器人步態(tài)檢測系統(tǒng)研究[D];北京林業(yè)大學(xué);2016年

10 李茜楠;基于Kinect的異常步態(tài)檢測[D];山東大學(xué);2016年

，

本文編號：1943497